-
Evaluation of the modified Pittsburgh classification for predicting the disease‐free survival outcome of squamous cell carcinoma of the external auditory canal
Cindy H. Nabuurs, Wietske Kievit, Nilou Labbé, Charles René Leemans, Conrad F. G. M. Smit, Michiel W. M. van den Brekel, +11 more
21citations -
Methotrexate plus or minus cetuximab as first‐line treatment in a recurrent or metastatic (R/M) squamous cell carcinoma population of the head and neck (SCCHN), unfit for cisplatin combination treatment, a phase Ib‐randomized phase II study Commence
Janneke C. Ham, Esther van Meerten, W. Edward Fiets, Laurens Victor Beerepoot, Frank J. F. Jeurissen, Marije Slingerland, +4 more
19citations -
The association between skeletal muscle mass and sensorineural hearing loss upon cisplatin‐based chemoradiotherapy in patients with head and neck squamous cell carcinoma
Anouk W. M. A. Schaeffers, Anouk V. M. Burger, Charlotte W. Duinkerken, Klaske E. van Sluis, Jan Paul de Boer, Lisette van der Molen, +6 more
1citations
10 results